The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2016

Filed:

Jul. 31, 2015
Applicant:

Allergy Research Group, Llc, Alameda, CA (US);

Inventor:

Robert Settineri, Irvine, CA (US);

Assignee:

ALLERGY RESEARCH GROUP, LLC, Alameda, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/28 (2006.01); A61K 31/122 (2006.01); A61K 31/661 (2006.01); A61K 31/7028 (2006.01); A61K 31/593 (2006.01); A61K 31/375 (2006.01); A61K 38/44 (2006.01); A61K 31/385 (2006.01); A61K 36/31 (2006.01); A61K 36/81 (2006.01); A61K 36/23 (2006.01); A61K 36/21 (2006.01); A61K 36/88 (2006.01); A61K 36/48 (2006.01); A61K 31/05 (2006.01); A61K 36/45 (2006.01); A61K 36/73 (2006.01); A61K 36/736 (2006.01); A61K 36/87 (2006.01); A23D 9/013 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 31/16 (2006.01); A61K 31/66 (2006.01); A61K 31/683 (2006.01); A61K 31/685 (2006.01); A61K 31/716 (2006.01); A61K 33/22 (2006.01);
U.S. Cl.
CPC ...
A61K 38/28 (2013.01); A23D 9/013 (2013.01); A23L 29/10 (2016.08); A23L 29/244 (2016.08); A23L 33/105 (2016.08); A23L 33/115 (2016.08); A61K 9/0056 (2013.01); A61K 31/05 (2013.01); A61K 31/122 (2013.01); A61K 31/16 (2013.01); A61K 31/375 (2013.01); A61K 31/385 (2013.01); A61K 31/593 (2013.01); A61K 31/66 (2013.01); A61K 31/661 (2013.01); A61K 31/683 (2013.01); A61K 31/685 (2013.01); A61K 31/7028 (2013.01); A61K 31/716 (2013.01); A61K 33/22 (2013.01); A61K 36/21 (2013.01); A61K 36/23 (2013.01); A61K 36/31 (2013.01); A61K 36/45 (2013.01); A61K 36/48 (2013.01); A61K 36/73 (2013.01); A61K 36/736 (2013.01); A61K 36/81 (2013.01); A61K 36/87 (2013.01); A61K 36/88 (2013.01); A61K 38/44 (2013.01); A61K 38/446 (2013.01); A61K 45/06 (2013.01); C12Y 111/01006 (2013.01); C12Y 115/01001 (2013.01); A23V 2002/00 (2013.01);
Abstract

Flavored chewable wafers containing nutritional supplement formulations suitable for enhancement of cell and mitochondrial function as well as providing antioxidants and aiding in weight loss and other desirable nutritional benefits comprises enriched formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients. These edible wafer lipid combinations can be used to treat mitochondrial disorders and other nutritional deficiencies associated with medical pathologies, chronic illnesses and syndromes, or to maintain lipid balance for normal mitochondrial function, and can be administered in pleasant tasting chewable wafers.


Find Patent Forward Citations

Loading…